The Pharmacy Research Group (PRG) is the latest addition
to the existing seven other distinct research groups within the
Research Institute in Healthcare Science (RIHS).
The PRG has been set up to develop and carry out well
coordinated research in Pharmacy, both at UG and PG levels,
establish internal and external research collaborations, generate
external grant income, and to publish in peer reviewed
The central theme of the research activities within the PRG
revolves around discovery, design, development and delivery of
drugs for the treatment of infections, cancers, diabetes and
cardiovascular diseases, and current issues in Pharmacy
The research within this group is managed by the Pharmacy
Research Management Team (PRMT) comprising Professor Satya Sarker
(Chair), Professor Michael Brown, Professor Ray
Fitzpatrick, Professor John Howl, Professor Rae Morgan (HoD
Pharmacy), Dr Claire Martin and Dr Paul Rutter.
Currently, there are 4 post-doctoral fellows, 15 PhD and 12 MSc
students supervised by the members of the PRG.
The PRG plans to work in close collaboration with at least four
recognised research groups within RIHS, namely:
Some members of the PRG already have established research
collaborations nationally and internationally, notably, links with
various international research groups in:
And in the UK in:
The PRG will continue with these collaborations, and hope to
extend its collaborations with other research groups globally.
Research within this division focuses on new ‘drug lead’
discovery from natural products as well as through rational drug
design, molecular modelling and synthesis for the treatment of
cancer, diabetes and infectious diseases.
This division also aims to extend its activities towards the
synthesis of nanoparticles and ‘molecular umbrellas’ for
pharmaceutical applications (eg drug delivery).
This division incorporates research expertise from the areas of
natural product chemistry, pharmaceutical microbiology, medicinal
and pharmaceutical chemistry, and natural medicine.
This division utilises its existing research strengths and
expertise in clinical trial, pharmaceutical formulations, liposomal
drug delivery and molecular pharmacology of new or currently
available anticancer, antidiabetic and antiinfective drugs.
This division also incorporates research in other modern drug
delivery systems including ultrasound delivery, peptide delivery
and ‘molecular umbrellas’. Research involving pharmaceutical
analysis and assay development are also included.
Research on various aspects of pharmacy practice (which
include safe and effective use of medicines, pharmacoeconomics
and service development), pharmacy education (pedagogy) and
prescription science (particularly, prescription pattern,
prescription quality and electronic prescriptions) is incorporated
within this division.
As part of the development of research culture and ethos within
the Department of Pharmacy, the PRG has started regular lunch time
journal club (8-9 annually) where all final year project students
as well as SAS staff are encouraged to attend. Various cutting-age
and current research topics and ideas are discussed in these
journal club sessions in an informal and relaxed environment.
For further information on post-doc, PhD, MSc/MPhil and research
collaboration opportunities, contact Professor Satya Sarker
University of Wolverhampton, Wulfruna Street, Wolverhampton, WV1 1LY
Course enquiries: 0800 953 3222, General enquiries: 01902 321000 | Email: firstname.lastname@example.org
Freedom of Information | Disclaimer and copyright | The University as a charity | Cookies Policy